Movano Health Faces Nasdaq Delisting Notice Over Price and Filing Requirements

Received Delisting Notice from Nasdaq Related to Minimum Bid Price Requirement and Late Filing of the Form 10-Q for the period ended March 31, 2025

PLEASANTON, Calif., July 11, 2025 /PRNewswire/ — Movano Health (Nasdaq: MOVE) (the “Company”) announced today that, on July 7, 2025, it received a delisting determination from The Nasdaq Capital Market with respect to the $1.00 per share bid price requirement (the “Bid Price Requirement”), as set forth in Listing Rule 5550(a)(2), and the late filing requirement, as set forth in Listing Rule 5250(c)(1), given the delay in filing its Form 10-Q for the quarter ended March 31, 2025 (the “Filing Requirement”)(together, the “Notice”). Accordingly, the Company plans to timely submit a request for a hearing before a Nasdaq Hearings Panel (the “Panel”). While the hearing request only stays suspension and delisting for 22 calendar days from the date of the Notice, the Company intends to request…